Literature DB >> 8579606

Calcitonin prevents CCl4-induced hydroperoxide generation and cytotoxicity possibly through C1b receptor in rat hepatocytes.

S Chen1, S Morimoto, M Tamatani, K Fukuo, T Nakahashi, A Nishibe, B Jiang, T Ogihara.   

Abstract

The effects of calcitonin (CT) on oxyradical generation and cellular damage induced by carbon tetrachloride (CCl4) were investigated in rat hepatocytes. Addition of CCl4 to the cells concentration dependently increased intracellular production of hydroperoxides and release of aspartate aminotransferase (AST) and alanine aminotransferase (ALT). The hepatocytes expressed mRNA for a CT receptor, C1b. Coaddition of CT to the cells concentration dependently suppressed the CCl4-induced increase in hydroperoxide production and also decreased the release of AST and ALT. The suppressive effect of CT on hydroperoxide production was reversed by further addition of H7 or by pretreatment with phorbol 12-myristate 13-acetate for 24 h. These results suggest that CT prevents CCl4-induced oxyradical production and cellular damage through activation of protein kinase C in hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8579606     DOI: 10.1006/bbrc.1996.0154

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  In vitro hepatoprotective and antioxidant activities of crude extract and isolated compounds from Ficus gnaphalocarpa.

Authors:  Donfack J Hubert; Amadou Dawe; Ngueguim T Florence; Kapche D W F Gilbert; Tchana N Angele; D Buonocore; P Vita Finzi; G Vidari; Ngadjui T Bonaventure; Fulvio Marzatico; Moundipa F Paul
Journal:  Inflammopharmacology       Date:  2010-11-19       Impact factor: 4.473

2.  In vitro assessment of hepatoprotective agents against damage induced by acetaminophen and CCl4.

Authors:  Liliana Torres González; Noemí Waksman Minsky; Linda Elsa Muñoz Espinosa; Ricardo Salazar Aranda; Jonathan Pérez Meseguer; Paula Cordero Pérez
Journal:  BMC Complement Altern Med       Date:  2017-01-13       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.